209 related articles for article (PubMed ID: 10958827)
1. Urinary composition and postprandial blood changes in H-secoisolariciresinol diglycoside (SDG) metabolites in rats do not differ between acute and chronic SDG treatments.
Rickard SE; Thompson LU
J Nutr; 2000 Sep; 130(9):2299-305. PubMed ID: 10958827
[TBL] [Abstract][Full Text] [Related]
2. Chronic exposure to secoisolariciresinol diglycoside alters lignan disposition in rats.
Rickard SE; Thompson LU
J Nutr; 1998 Mar; 128(3):615-23. PubMed ID: 9482772
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed.
Rickard SE; Orcheson LJ; Seidl MM; Luyengi L; Fong HH; Thompson LU
J Nutr; 1996 Aug; 126(8):2012-9. PubMed ID: 8759374
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.
Setchell KD; Brown NM; Zimmer-Nechemias L; Wolfe B; Jha P; Heubi JE
Food Funct; 2014 Mar; 5(3):491-501. PubMed ID: 24429845
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J
Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060
[TBL] [Abstract][Full Text] [Related]
6. Accessibility of ³H-secoisolariciresinol diglycoside lignan metabolites in skeletal tissue of ovariectomized rats.
Sacco SM; Thompson LU; Ganss B; Ward WE
J Med Food; 2011 Oct; 14(10):1208-14. PubMed ID: 21663478
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.
Kitts DD; Yuan YV; Wijewickreme AN; Thompson LU
Mol Cell Biochem; 1999 Dec; 202(1-2):91-100. PubMed ID: 10705999
[TBL] [Abstract][Full Text] [Related]
8. Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats.
Felmlee MA; Woo G; Simko E; Krol ES; Muir AD; Alcorn J
Br J Nutr; 2009 Aug; 102(3):361-9. PubMed ID: 19216812
[TBL] [Abstract][Full Text] [Related]
9. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside.
Rickard SE; Yuan YV; Thompson LU
Cancer Lett; 2000 Dec; 161(1):47-55. PubMed ID: 11078912
[TBL] [Abstract][Full Text] [Related]
10. Cytostatic inhibition of cancer cell growth by lignan secoisolariciresinol diglucoside.
Ayella A; Lim S; Jiang Y; Iwamoto T; Lin D; Tomich J; Wang W
Nutr Res; 2010 Nov; 30(11):762-9. PubMed ID: 21130295
[TBL] [Abstract][Full Text] [Related]
11. Prolonged administration of secoisolariciresinol diglycoside increases lignan excretion and alters lignan tissue distribution in adult male and female rats.
Saarinen NM; Thompson LU
Br J Nutr; 2010 Sep; 104(6):833-41. PubMed ID: 20388250
[TBL] [Abstract][Full Text] [Related]
12. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats.
Tou JC; Chen J; Thompson LU
J Nutr; 1998 Nov; 128(11):1861-8. PubMed ID: 9808635
[TBL] [Abstract][Full Text] [Related]
13. Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.
Adolphe JL; Whiting SJ; Juurlink BH; Thorpe LU; Alcorn J
Br J Nutr; 2010 Apr; 103(7):929-38. PubMed ID: 20003621
[TBL] [Abstract][Full Text] [Related]
14. Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside.
Roncaglia L; Amaretti A; Raimondi S; Leonardi A; Rossi M
Appl Microbiol Biotechnol; 2011 Oct; 92(1):159-68. PubMed ID: 21614502
[TBL] [Abstract][Full Text] [Related]
15. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone.
Wang LQ; Meselhy MR; Li Y; Qin GW; Hattori M
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1606-10. PubMed ID: 11086885
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel metabolites of flaxseed lignans in vitro and in vivo.
Quartieri A; García-Villalba R; Amaretti A; Raimondi S; Leonardi A; Rossi M; Tomàs-Barberàn F
Mol Nutr Food Res; 2016 Jul; 60(7):1590-601. PubMed ID: 26873880
[TBL] [Abstract][Full Text] [Related]
17. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis.
Thompson LU; Rickard SE; Orcheson LJ; Seidl MM
Carcinogenesis; 1996 Jun; 17(6):1373-6. PubMed ID: 8681458
[TBL] [Abstract][Full Text] [Related]
18. Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process.
Fuentealba C; Figuerola F; Estévez AM; Bastías JM; Muñoz O
J Sci Food Agric; 2014 Jul; 94(9):1729-38. PubMed ID: 24243589
[TBL] [Abstract][Full Text] [Related]
19. Protective Role of Flaxseed Oil and Flaxseed Lignan Secoisolariciresinol Diglucoside Against Oxidative Stress in Rats with Metabolic Syndrome.
Pilar B; Güllich A; Oliveira P; Ströher D; Piccoli J; Manfredini V
J Food Sci; 2017 Dec; 82(12):3029-3036. PubMed ID: 29083494
[TBL] [Abstract][Full Text] [Related]
20. The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1.
Ren GY; Chen CY; Chen WG; Huang Y; Qin LQ; Chen LH
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1303-1310. PubMed ID: 27849354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
